GelMEDIX

InGel Therapeutics

The company develops stem-cell therapies and biodegradable hydrogels for patients suffering from retinal degeneration and blinding diseases like retinitis pigmentosa.

Healome

Healome Therapeutics develops eye-drop matrix technology that restructures on the ocular surface to provide long-acting lubrication and drug delivery for patients with eye diseases.

InGel

This biotechnology company develops engineered cell therapies and biodegradable polymers to treat retinal degeneration for patients with blinding eye diseases.

Aviceda Therapeutics

This biotechnology firm develops glycan-coated nanoparticle therapeutics to treat geographic atrophy and other inflammatory diseases for patients with vision loss.

Healome Therapeutics

The company develops eye-drop matrix technology to improve drug delivery and treatment for patients with ocular surface diseases.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

Ikarovec

This company develops bicistronic gene therapies to treat chronic ophthalmic diseases, such as age-related macular degeneration, for patients suffering from vision loss.

RhyGaze

This biotechnology company develops optogenetic gene therapies to restore vision for patients with retinal diseases causing blindness.